Telephone-Based Coaching Sessions (TAC) to Improve Advance Care Planning Participation in Advanced Cancer Patients and Their Support Person
Part of paid clinical trials in Everett, Washington.
- Sponsor
- Fred Hutchinson Cancer Center
- Study ID
- NCT07141407
- Status
- Recruiting
Conditions
- Advanced Malignant Solid Neoplasm
- Hematopoietic and Lymphatic System Neoplasm
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Supportive Care — OTHERAttend TAC telephone-based coaching sessions
- Telephone-Based Intervention — BEHAVIORALAttend TAC telephone-based coaching sessions
- Survey Administration — OTHERAncillary studies
- Educational Intervention — OTHERReceive an ACP brochure/handout
Study Details
This clinical trial studies whether telephone-based coaching sessions, Talking About Cancer (TAC), work to improve engagement in advance care planning (ACP) in patients with cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) and their support person. Participation in ACP, which includes having end of life (EOL) care conversations and completing advance directives (e.g., living will, health care proxy, do not resuscitate order), improves quality EOL care. Despite this, less than half of patients with advanced cancer have EOL care conversations or complete advance directives. TAC coaching sessions are delivered by a social worker over the phone. They are designed to help patients and their support person communicate about ACP, manage the distress these conversations can cause, and participate in the process of ACP with a clear action plan of having goals-of-care conversations and completing advance directives. This may be an effective way to improve ACP participation in advanced cancer patients and their support person.
Key Dates
- Start date
- Apr 8, 2026
- Status verified
- Feb 2026
- Primary completion
- Oct 12, 2026
- Completion
- Dec 14, 2026
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Arm I (TAC sessions)Participants attend Talking About Cancer (TAC) telephone-based coaching sessions (2 sessions) designed to support participants in communicating about advance care planning (ACP), managing distress around ACP conversations, engaging in the process of ACP, and completing advance directives over 45-60 minutes each once a week (QW) for 2 weeks.
- Active Comparator: Arm II (enhanced usual care)Participants receive an ACP brochure/handout on study.
Primary Outcome Measure
Enrollment rate (Feasibility) [ Time Frame: At 6-weeks post-randomization ]
Central Contacts
- Megan Shen, PhD206-667-4172
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Providence Regional Cancer Partnership | Everett | Washington | 98201 | Megan Bannister, MSW, LSWAIC (PRINCIPAL_INVESTIGATOR) |
| Skagit Regional Health Cancer Care Center | Mount Vernon | Washington | 98274 | Kiarash Kojouri, MD (PRINCIPAL_INVESTIGATOR) |
| Fred Hutch/University of Washington Cancer Consortium | Seattle | Washington | 98109 | Megan Shen, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Everett, WA
Related Studies
- Collection and Storage of Tissue and Blood Samples From Patients With CancerRecruiting · National Cancer Institute LAO · Birmingham, Alabama
- Sustained Oral Fiber Supplementation for Patients Undergoing Donor Stem Cell Transplantation for Hematological MalignanciesRecruiting · Fred Hutchinson Cancer Center · Seattle, Washington
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialPHASE2 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic DiseasesPHASE2 · Recruiting · Fred Hutchinson Cancer Center · Seattle, Washington